Product Information
ATOVAQUONE-PROGUANIL 62.5-25 is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $1.2264 per EA under NDC 68462040201. Its NADAC has been published 407 times since Oct 21, 2015.
Strength
62.5; 25 mg/1; mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462040201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ATOVAQUONE; PROGUANIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091211On Market Since
4/8/2015
Pharmacological Classes
Price Statistics
The NADAC for ATOVAQUONE-PROGUANIL 62.5-25 has been published 407 times since Oct 21, 2015, and over the history we have for it it has declined 31.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2264 per EA |
|---|---|
| All-time high | $1.7844 (Feb 10, 2016) |
| All-time low | $0.6264 (Sep 21, 2022) |
| 52-week high | $1.3157 |
| 52-week low | $1.1576 |
| Median price | $1.3116 |
| Average price | $1.3212 |
| Largest weekly change | -62.2% (Sep 21, 2022) |
| Weeks tracked | 407 |
| Tracking since | Oct 21, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Atovaquone and Proguanil Hydrochloride Pediatric market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ATOVAQUONE-PROGUANIL 62.5-25?
The current National Average Drug Acquisition Cost (NADAC) for ATOVAQUONE-PROGUANIL 62.5-25, manufactured by Glenmark Pharmaceuticals Inc., USA, is $1.2264 per EA (NDC 68462040201), effective Jun 24, 2026.
How has the price of ATOVAQUONE-PROGUANIL 62.5-25 changed over time?
Over the history we have for it, the NADAC for ATOVAQUONE-PROGUANIL 62.5-25 has declined 31.3%. It has been tracked across 407 weekly CMS publications since Oct 21, 2015.
What are the highest and lowest recorded NADAC prices for ATOVAQUONE-PROGUANIL 62.5-25?
Since Oct 21, 2015, the NADAC for ATOVAQUONE-PROGUANIL 62.5-25 has ranged from a low of $0.6264 (Sep 21, 2022) to a high of $1.7844 (Feb 10, 2016), with a median of $1.3116 per EA.
Are there cheaper alternatives to ATOVAQUONE-PROGUANIL 62.5-25?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ATOVAQUONE-PROGUANIL 62.5-25, so no direct lower-cost alternative is listed.
Who manufactures ATOVAQUONE-PROGUANIL 62.5-25?
ATOVAQUONE-PROGUANIL 62.5-25 (NDC 68462040201) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification